Abstract
The issue of conflict of interest management and authorship has been the subject of debates and recommendations over the past 15 years1–7. Some grey areas persist concerning the definition of authorship in industry-sponsored clinical trials (IRCT)8. The objective of the present study was to better understand this process.
This article is protected by copyright. All rights reserved.
http://ift.tt/2m8tIa4
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου